abstract |
The present disclosure relates to contact lens solution comprising cyclodextrin, ophthalmic solutions comprising cyclodextrin for treating disorders or conditions associated with wearing of contact lenses, methods of treating such disorders or conditions using the ophthalmic cyclodextrin solutions, and kits and combination products thereof. |